ATE525396T1 - Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn - Google Patents

Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn

Info

Publication number
ATE525396T1
ATE525396T1 AT01964104T AT01964104T ATE525396T1 AT E525396 T1 ATE525396 T1 AT E525396T1 AT 01964104 T AT01964104 T AT 01964104T AT 01964104 T AT01964104 T AT 01964104T AT E525396 T1 ATE525396 T1 AT E525396T1
Authority
AT
Austria
Prior art keywords
slo2
potassium channel
channel proteins
slo4
human brain
Prior art date
Application number
AT01964104T
Other languages
English (en)
Inventor
Timothy Jegla
Julie Witzel
Original Assignee
Icagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icagen Inc filed Critical Icagen Inc
Application granted granted Critical
Publication of ATE525396T1 publication Critical patent/ATE525396T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01964104T 2000-11-15 2001-08-15 Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn ATE525396T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24911200P 2000-11-15 2000-11-15
US09/921,159 US7041494B2 (en) 2000-11-15 2001-08-01 DNA encoding Slo2 and Slo4, potassium channel
PCT/US2001/025701 WO2002040649A1 (en) 2000-11-15 2001-08-15 Slo2 and slo4, novel potassium channel proteins from human brain

Publications (1)

Publication Number Publication Date
ATE525396T1 true ATE525396T1 (de) 2011-10-15

Family

ID=26939832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964104T ATE525396T1 (de) 2000-11-15 2001-08-15 Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn

Country Status (7)

Country Link
US (4) US7041494B2 (de)
EP (2) EP1334178B1 (de)
JP (1) JP2005507633A (de)
AT (1) ATE525396T1 (de)
AU (2) AU8499501A (de)
CA (1) CA2428350A1 (de)
WO (1) WO2002040649A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1505150A1 (de) * 2002-05-14 2005-02-09 Takeda Pharmaceutical Company Limited Neue proteine und deren dnas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1029042A4 (de) * 1997-10-22 2004-10-13 Univ Washington Ein ph-empfindlicher calciumkanalin spernatozyten
US20030143676A1 (en) * 1999-03-25 2003-07-31 Genesis Research And Development Corporation Limited Fibroblast growth factor receptors and methods for their use
US6972187B2 (en) * 2000-05-12 2005-12-06 Millennium Pharmaceuticals, Inc. OAT5 molecules and uses therefor
US20040009474A1 (en) * 2000-05-24 2004-01-15 Leach Martin D. Novel human polynucleotides and polypeptides encoded thereby
US20020048787A1 (en) * 2000-06-14 2002-04-25 Ming-Hui Wei Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
JP2004533205A (ja) * 2000-08-03 2004-11-04 インサイト・ゲノミックス・インコーポレイテッド 輸送体及びイオンチャネル
WO2003000842A2 (en) * 2001-06-04 2003-01-03 Curagen Corporation Novel proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
WO2002040649A1 (en) 2002-05-23
CA2428350A1 (en) 2002-05-23
US7767450B2 (en) 2010-08-03
WO2002040649A8 (en) 2002-11-07
US20100267930A1 (en) 2010-10-21
EP1334178A1 (de) 2003-08-13
US7893209B2 (en) 2011-02-22
US7411043B2 (en) 2008-08-12
US20030017533A1 (en) 2003-01-23
JP2005507633A (ja) 2005-03-24
EP1334178B1 (de) 2011-09-21
EP1334178A4 (de) 2006-03-29
EP2295454A1 (de) 2011-03-16
US20090017534A1 (en) 2009-01-15
US20060099640A1 (en) 2006-05-11
AU2001284995B2 (en) 2007-03-29
AU8499501A (en) 2002-05-27
US7041494B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
DE69833014D1 (de) Menschliche toll homologen
EP1124846A4 (de) Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden
DE60134136D1 (de) Zytokinrezeptoruntereinheit-proteine aus säugetieren, damit zusammenhängende reagenzien und methoden
CY1109725T1 (el) Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
AU2001294541A1 (en) Mammalian genes; related reagents and methods
NO2010021I1 (no) Denosumab
EA200600042A1 (ru) Способы образования дисульфидных связей и гликозилирования белков и реагенты, применяемые в этих способах
DE60041697D1 (de) Säugetier-rezeptorproteine; ähnliche reagentien und methoden
DE69728897D1 (de) Saeugetierchemokine
EP1183330A4 (de) Kv10.1, EIN NEUER POTENTIAL-ABHÄNGIGER KALIUMKANAL DES MENSCHLICHEN GEHIRNS
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
ATE525396T1 (de) Slo2 und slo4, neue kaliumkanal-proteine aus menschlichem gehirn
ATE330011T1 (de) Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2002079479A3 (en) Motor proteins and methods for their use
WO2001087932A3 (en) Seven transmembrane proteins and polynucleotides encoding the same
WO2004053142A3 (en) P53-associated parkin-like cytoplasmic protein, and related compositions and methods
WO2003004678A3 (en) Novel receptors
WO2001094417A3 (en) Novel human seven transmembrane proteins and polynucleotides encoding the same
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
WO2001098314A3 (en) Novel motor proteins and methods for their use
WO2003048320A3 (en) Novel motor protein of p. falciparum and methods for its use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties